Registration No. 333-______

                       SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C.

                                    FORM S-8

                          REGISTRATION STATEMENT UNDER
                           THE SECURITIES ACT OF 1933


                               VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)

            Delaware                                      11-2871434
   (State or other jurisdiction of             (IRS Employer Identification No.)
    incorporation or organization)

 180 Linden Avenue, Westbury, New York                      11590
(Address of principal executive offices)                 (Zip Code)

              VASOMEDICAL, INC. 1997 STOCK OPTION PLAN, AS AMENDED
                            (Full title of the plan)

                           Anthony Viscusi, President
                               Vasomedical, Inc.
                               180 Linden Avenue
                            Westbury, New York 11590
                    (Name and address of agent for service)

                                 (516) 997-4600
         (Telephone number, including area code, of agent for service)

                                    copy to:
                            David H. Lieberman, Esq.
                    Blau, Kramer, Wactlar & Lieberman, P.C.
                             100 Jericho Quadrangle
                            Jericho, New York 11753
                                 (516) 822-4820

                        CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
===================================================================================================
                                          Proposed maximum     Proposed maximum
Title of securities      Amount to be     offering price per   aggregate offering      Amount of
  to be registered      Registered (1)      security (2)            price (2)      registration fee
---------------------------------------------------------------------------------------------------
 <S>                 <C>                        <C>                 <C>                   <C>
 Common Stock,
  par value $.001    1,000,000 shs. (3)(4)      $1.4065              $1,406,500           $391
  per share
===================================================================================================
<FN>
(1) The Registration  statement also covers an indeterminate number of shares of
Common Stock which may become issuable  pursuant to anti-dilution and adjustment
provisions of the plan.
(2) Estimated solely for the purpose of calculating the registration  fee, based
upon the  average  of the high and low  prices  of the  Company's  Common  Stock
reported on Nasdaq on August 10, 1999, pursuant to Rule 457.
(3) Represents additional shares of Common Stock issuable under the Vasomedical,
Inc. 1997 Stock Option Plan, as amended.
(4) Pursuant to Rule 457, a registration  fee of $391 is payable with respect to
the additional  1,000,000 shares of Common Stock issuable under the Vasomedical,
Inc. 1997 Stock Option Plan, as amended.
</FN>
</TABLE>
<PAGE>
                                    PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.
        ---------------------------------------

     This  Registration  Statement  on Form S-8 is being  filed to  register  an
additional  1,000,000  shares of Common Stock  available for issuance  under the
Registrant's  1997 Stock  Option  Plan,  as  amended.  An  initial  Registration
Statement on Form S-8  (Registration  Statement No.  333-60471)  was  previously
filed with  respect to that plan.  The  contents  of such  earlier  Registration
Statement No. 333-60471 are hereby incorporated by reference.

     All documents filed pursuant to Sections 13(a),  13(c), 14 and 15(d) of the
Securities  Exchange Act of 1934 after the date of this  Registration  Statement
and prior to the termination of this offering of Common Stock shall be deemed to
be  incorporated  by reference in this  Registration  Statement and to be a part
hereof from the date of filing of such documents.  Any statement  contained in a
document  incorporated  or  deemed  to be  incorporated  by  reference  in  this
Registration Statement shall be deemed to be modified or superseded for purposes
of this Registration  Statement to the extent that a statement  contained herein
or  in  any  subsequently  filed  document  that  also  is or  is  deemed  to be
incorporated by reference  herein  modifies or supercedes  such  statement.  Any
statement so modified or superseded  shall not be deemed,  except as so modified
or superseded, to constitute a part of this Registration Statement.

     The Company  will provide  without  charge to each person to whom a copy of
this  Registration  Statement is delivered,  upon the written or oral request of
such person,  a copy of any or all of the  documents  incorporated  by reference
(except for  exhibits  thereto  unless  specifically  incorporated  by reference
therein).  Requests  for  such  copies  should  be  directed  to the  Secretary,
Vasomedical,  Inc., 180 Linden Avenue,  Westbury, New York 11590, (516) 997-4600
ext.790.

Item 8. Exhibits.
        --------

          4    1997 Stock Option Plan, as amended

          5    Opinion and consent of Blau, Kramer, Wactlar & Lieberman, P.C.

          23.1 Consent of Blau, Kramer, Wactlar & Lieberman,  P.C. - included in
               their opinion filed as Exhibit 5

          23.2 Consent of Grant Thornton LLP

          24   Power of Attorney - included in signature page hereof
<PAGE>

                                   SIGNATURES

        Pursuant  to  the  requirements  of the  Securities  Act  of  1933,  the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf thereunto duly authorized, in Westbury, New
York on the 16th day of August, 1999.

                              VASOMEDICAL, INC.
                              By: /s/ Anthony Viscusi
                              -----------------------
                              Anthony Viscusi, President and Chief Executive
                              Officer and Director (Principal Executive Officer)

                               POWER OF ATTORNEY

        KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears
below constitutes and appoints Anthony Viscusi and Joseph A. Giacalone, and each
of them, his true and lawful  attorneys-in-fact  and agents,  with full power of
substitution  and  resubstitution,  for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-effective
amendments)  to this  Registration  Statement  and to file  the  same,  with all
exhibits  thereto,  and  other  documents  in  connection  therewith,  with  the
Securities and Exchange  Commission,  granting unto said  attorneys-in-fact  and
agents,  and each of them,  full power and  authority to do and perform each and
every act and thing  requisite and necessary to be done, as fully to all intents
and purposes as he might or could do in person,  hereby ratifying and confirming
all that  said  attorneys-in-fact  and  agents  or any of them,  or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

        In accordance with the  requirements of the Securities Act of 1933, this
registration  statement  was signed by the following  persons in the  capacities
indicated on August 16, 1999.

      Signatures                         Title
      ----------                         -----
/s/ Alexander G. Bearn          Director
Alexander G. Bearn

/s/ David S. Blumenthal         Director
David S. Blumenthal

/s/ Francesco Bolgiani          Director
Francesco Bolgiani

/s/ Abraham E. Cohen            Chairman of the Board
Abraham E. Cohen

/s/ Joseph A. Giacalone         Secretary and Treasurer (Principal
Joseph A. Giacalone             Financial and Accounting Officer)

/s/ John C.K. Hui               Director
John C. K. Hui

_____________________           Director
Kenneth W. Rind

/s/ E. Donald Shapiro           Director
E. Donald Shapiro

/s/ Anthony Viscusi             President, Chief Executive Officer and
Anthony Viscusi                 Director (Principal Executive Officer)

/s/ Zhen-sheng Zheng            Director
Zhen-sheng Zheng
<PAGE>
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549




                               Vasomedical, Inc.





                        Form S-8 Registration Statement




                          E X H I B I T    I N D E X



                                                         Page No. in Sequential
Exhibit                                                  Numbering of all Pages,
Number         Exhibit Description                       including Exhibit Pages
--------------------------------------------------------------------------------

4       1997 Stock Option Plan, as amended............

5       Opinion and Consent of Counsel................

23.1    Consent of Counsel............................       See Exhibit 5

23.2    Consent of Grant Thornton LLP.................

24      Power of Attorney.............................       See signature page
[{"type": "S-8", "sequence": "1", "secsgml_size_bytes": 9552}]
{"company-data": {"conformed-name": "VASOMEDICAL INC", "cik": "0000839087", "assigned-sic": "3845", "irs-number": "112871434", "state-of-incorporation": "DE", "fiscal-year-end": "0531"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-85455", "film-number": "99695118"}, "business-address": {"street1": "180 LINDEN AVENUE", "city": "WESTBURY", "state": "NY", "zip": "11590", "phone": "5169974600"}, "mail-address": {"street1": "150 MOTOR PARKWAY", "street2": "SUITE 408", "city": "HAUPPAUGE", "state": "NY", "zip": "11788"}, "former-company": [{"former-conformed-name": "FUTURE MEDICAL PRODUCTS INC /DE/", "date-changed": "19920703"}, {"former-conformed-name": "FUTURE MEDICAL PRODUCTS INC /NY/", "date-changed": "19920506"}]}
Registration No. 333-______

                       SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C.

                                    FORM S-8

                          REGISTRATION STATEMENT UNDER
                           THE SECURITIES ACT OF 1933

                               VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)

            Delaware                                      11-2871434
   (State or other jurisdiction of             (IRS Employer Identification No.)
    incorporation or organization)

 180 Linden Avenue, Westbury, New York                      11590
(Address of principal executive offices)                 (Zip Code)

              VASOMEDICAL, INC. 1997 STOCK OPTION PLAN, AS AMENDED
                            (Full title of the plan)

                           Anthony Viscusi, President
                               Vasomedical, Inc.
                               180 Linden Avenue
                            Westbury, New York 11590
                    (Name and address of agent for service)

                                 (516) 997-4600
         (Telephone number, including area code, of agent for service)

                                    copy to:
                            David H. Lieberman, Esq.
                    Blau, Kramer, Wactlar & Lieberman, P.C.
                             100 Jericho Quadrangle
                            Jericho, New York 11753
                                 (516) 822-4820

                        CALCULATION OF REGISTRATION FEE
===================================================================================================
                                          Proposed maximum     Proposed maximum
Title of securities      Amount to be     offering price per   aggregate offering      Amount of
  to be registered      Registered (1)      security (2)            price (2)      registration fee
---------------------------------------------------------------------------------------------------
Common Stock,
  par value $.001    1,000,000 shs. (3)(4)      $1.4065              $1,406,500           $391
  per share
===================================================================================================
(1) The Registration  statement also covers an indeterminate number of shares of
Common Stock which may become issuable  pursuant to anti-dilution and adjustment
provisions of the plan.
(2) Estimated solely for the purpose of calculating the registration  fee, based
upon the  average  of the high and low  prices  of the  Company's  Common  Stock
reported on Nasdaq on August 10, 1999, pursuant to Rule 457.
(3) Represents additional shares of Common Stock issuable under the Vasomedical,
Inc. 1997 Stock Option Plan, as amended.
(4) Pursuant to Rule 457, a registration  fee of $391 is payable with respect to
the additional  1,000,000 shares of Common Stock issuable under the Vasomedical,
Inc. 1997 Stock Option Plan, as amended.
PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.
        ---------------------------------------

     This  Registration  Statement  on Form S-8 is being  filed to  register  an
additional  1,000,000  shares of Common Stock  available for issuance  under the
Registrant's  1997 Stock  Option  Plan,  as  amended.  An  initial  Registration
Statement on Form S-8  (Registration  Statement No.  333-60471)  was  previously
filed with  respect to that plan.  The  contents  of such  earlier  Registration
Statement No. 333-60471 are hereby incorporated by reference.

     All documents filed pursuant to Sections 13(a),  13(c), 14 and 15(d) of the
Securities  Exchange Act of 1934 after the date of this  Registration  Statement
and prior to the termination of this offering of Common Stock shall be deemed to
be  incorporated  by reference in this  Registration  Statement and to be a part
hereof from the date of filing of such documents.  Any statement  contained in a
document  incorporated  or  deemed  to be  incorporated  by  reference  in  this
Registration Statement shall be deemed to be modified or superseded for purposes
of this Registration  Statement to the extent that a statement  contained herein
or  in  any  subsequently  filed  document  that  also  is or  is  deemed  to be
incorporated by reference  herein  modifies or supercedes  such  statement.  Any
statement so modified or superseded  shall not be deemed,  except as so modified
or superseded, to constitute a part of this Registration Statement.

     The Company  will provide  without  charge to each person to whom a copy of
this  Registration  Statement is delivered,  upon the written or oral request of
such person,  a copy of any or all of the  documents  incorporated  by reference
(except for  exhibits  thereto  unless  specifically  incorporated  by reference
therein).  Requests  for  such  copies  should  be  directed  to the  Secretary,
Vasomedical,  Inc., 180 Linden Avenue,  Westbury, New York 11590, (516) 997-4600
ext.790.

Item 8. Exhibits.
        --------

          4    1997 Stock Option Plan, as amended

          5    Opinion and consent of Blau, Kramer, Wactlar & Lieberman, P.C.

          23.1 Consent of Blau, Kramer, Wactlar & Lieberman,  P.C. - included in
               their opinion filed as Exhibit 5

          23.2 Consent of Grant Thornton LLP

          24   Power of Attorney - included in signature page hereof
SIGNATURES

        Pursuant  to  the  requirements  of the  Securities  Act  of  1933,  the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf thereunto duly authorized, in Westbury, New
York on the 16th day of August, 1999.

                              VASOMEDICAL, INC.
                              By: /s/ Anthony Viscusi
                              -----------------------
                              Anthony Viscusi, President and Chief Executive
                              Officer and Director (Principal Executive Officer)

                               POWER OF ATTORNEY

        KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears
below constitutes and appoints Anthony Viscusi and Joseph A. Giacalone, and each
of them, his true and lawful  attorneys-in-fact  and agents,  with full power of
substitution  and  resubstitution,  for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-effective
amendments)  to this  Registration  Statement  and to file  the  same,  with all
exhibits  thereto,  and  other  documents  in  connection  therewith,  with  the
Securities and Exchange  Commission,  granting unto said  attorneys-in-fact  and
agents,  and each of them,  full power and  authority to do and perform each and
every act and thing  requisite and necessary to be done, as fully to all intents
and purposes as he might or could do in person,  hereby ratifying and confirming
all that  said  attorneys-in-fact  and  agents  or any of them,  or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

        In accordance with the  requirements of the Securities Act of 1933, this
registration  statement  was signed by the following  persons in the  capacities
indicated on August 16, 1999.

      Signatures                         Title
      ----------                         -----
/s/ Alexander G. Bearn          Director
Alexander G. Bearn

/s/ David S. Blumenthal         Director
David S. Blumenthal

/s/ Francesco Bolgiani          Director
Francesco Bolgiani

/s/ Abraham E. Cohen            Chairman of the Board
Abraham E. Cohen

/s/ Joseph A. Giacalone         Secretary and Treasurer (Principal
Joseph A. Giacalone             Financial and Accounting Officer)

/s/ John C.K. Hui               Director
John C. K. Hui

_____________________           Director
Kenneth W. Rind

/s/ E. Donald Shapiro           Director
E. Donald Shapiro

/s/ Anthony Viscusi             President, Chief Executive Officer and
Anthony Viscusi                 Director (Principal Executive Officer)

/s/ Zhen-sheng Zheng            Director
Zhen-sheng Zheng
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                               Vasomedical, Inc.

                        Form S-8 Registration Statement

                          E X H I B I T    I N D E X

                                                         Page No. in Sequential
Exhibit                                                  Numbering of all Pages,
Number         Exhibit Description                       including Exhibit Pages
--------------------------------------------------------------------------------

4       1997 Stock Option Plan, as amended............

5       Opinion and Consent of Counsel................

23.1    Consent of Counsel............................       See Exhibit 5

23.2    Consent of Grant Thornton LLP.................

24      Power of Attorney.............................       See signature page